Amkay Product LTD IPO

Amkay Products Limited manufactures and markets a wide range of medical devices, disposables, and healthcare products, catering to various healthcare facilities across India. With a portfolio comprising over 30 products, the company focuses on respiratory disease-related medical devices, surgical disposables, home healthcare products, and more. Its manufacturing facility, located in Thane, Maharashtra, is equipped with the necessary infrastructure to ensure quality production.

Financial Performance:

While Amkay Products Limited has seen growth in net worth and profit after tax, its total revenue and total assets have decreased in recent years. However, the company remains committed to its objectives, including funding capital expenditure, meeting working capital requirements, and pursuing general corporate purposes.

Strengths and Weaknesses:

Amkay Products Limited boasts a robust portfolio, an extensive dealer network, and strong quality assurance measures. However, it faces challenges such as raw material sourcing risks, dependence on key customers, legal proceedings, and declining revenue. Investors should carefully weigh these factors before making investment decisions.

IPO Details:

The IPO is scheduled from April 30 to May 3, 2024, with a price range of Rs. 52 to Rs. 55 per share. The issue size amounts to Rs. 12.61 crore, with shares allocated to retail, institutional, and non-institutional investors. The company aims to utilize the proceeds for capital expenditure, working capital requirements, and general corporate purposes.

Conclusion:

Amkay Products Limited operates in a competitive market, and its financial performance has faced challenges in recent years. Seasoned investors are advised to conduct thorough due diligence and consider these factors before participating in the IPO.

Know More About Amkay Product IPO